3 Accelerator alumni win AI in Health and Care Awards

Accelerator alumni, Mendelian, Cibiltech and Ibex, have secured funding through the third competition of the Artificial Intelligence in Health and Care Awards.

The awards are run by the NHS AI Lab in partnership with the National Institute for Health and Care Research and the Accelerated Access Collaborative and nine project were chosen in total to received funding in this latest round. The funding covers phases 2, 3 and 4, with Phase 2 supporting early stage concepts and prototypes, to support development and evaluation. Phases 3 and 4 meanwhile support testing and further adoption across health and care.

Mendelian Ltd (Cohort 5) – £1,430,848
Mendelian’s product, Mendelscan uses AI to diagnose rare diseases using primary care electronic health records and could lead to people accessing treatments sooner and improved care.

Dr. Peter Fish, CEO of Mendelian, said, “We’re thrilled to have the opportunity to deploy our technology further into the NHS, the AI Award gives us the ability to show our impact at a population level. We’re very grateful for the support we received from DigitalHealth.London, the networking and exposure it brought us has been invaluable.”

Cibiltech (Cohort 6) – £1,141,441
Cibiltech’s solution iBox uses AI to predict long-term kidney transplant survival, which could help to improve and prolong the lives of people who have chronic kidney disease.

“We are honoured to have been selected as a winner of the AI Award,” said Stéphane Hoareau CEO of Cibiltech. “This award is a testament to the hard work and dedication of our team, and we are thrilled to have the opportunity to further our mission of preventing organ failure through the use of AI. We look forward to conducting our clinical trial and continuing to innovate in the field of MedTech.”

“The unwavering support of DigitalHealth.London has enabled us to get to know the different players in the UK health and innovation sector,” says Charles Brioix, CMO of Cibiltech.

Ibex Medical Analytics (Cohort 4) – £1,542,993
Ibex’s technology, Galen Breast, uses AI to analyse breast tissue, taken to test for cancer, which could help to diagnose breast cancer sooner, improve accuracy and reduce clinicians’ workloads.

“We are so proud to win the AI Award again! The award will help us in driving deployment of our technology across five NHS trusts to evaluate how it improves breast cancer diagnosis and reduce review time” said Tal Frieman, VP Marketing at Ibex Medical Analytics.

“Through the DigitalHealth.London programme we increased our understanding of the NHS and the relevant pathways where our products can support clinicians and ultimately help patients. The access to NHS professionals and experts in the implementation of digital innovations within the NHS was a fantastic and unique opportunity for us.”

The other winners include:

  • University Hospital Coventry and Warwickshire NHS Trust
  • Royal United Hospitals Bath NHS Foundation Trust
  • Oxford Cancer Biomarkers Limited
  • Icometrix
  • University of Bristol (Tommy’s App) 
  • Medtronic Limited

Find out more about the AI in Health and Care Award and the winners here.

Mendelian, Cibiltech and Ibex are alumni of the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator is a collaborative programme funded by two of London’s Academic Health Science Networks – UCLPartners and the Health Innovation Network – MedCity, CW+ and receives match funding from the European Regional Development Fund.